DavidJSnyderMD

PubMed

• 6 citations
  Rivaroxaban-induced serum sickness after total knee arthroplasty
  David J. Snyder, F. Bahar Matusik> ;American Journal of Health-System Pharmacy. 2015 Sep 15
• 33 citations
  Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas
  Catherine Flores, Christina Pham, David Snyder, Shicheng Yang, Luis Sanchez-Perez, Elias Sayour, Xiuyu Cui, Hanna Kemeny, Henry S. Friedman, Darell D. Bigner, John H. ...> ;Oncoimmunology. 2015 Jan 22
• Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.
  Sanchez-Perez LA, Choi BD, Archer GE, Cui X, Flores C, Johnson LA, Schmittling RJ, Snyder D, Herndon JE, Bigner DD, Mitchell DA, Sampson JH> ;PLoS ONE. 2013-01-01
• A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.
  Kirschbaum MH, Stein AS, Popplewell L, Delioukina M, Chen R, Nakamura R, Snyder D, Conrad J, Lacey SF, Frankel P, Dagis A, Nademanee A, Forman SJ> ;Biol. Blood Marrow Transplant.. 2012-03-01
• Rapidly Regulating Platelet Activity In Vivo With an Antidote Controlled Platelet Inhibitor.
  Nimjee, S.M., Lohrmann, J.D., Wang, H., Snyder, D.J., Cummings, T.J., Becker, R.C., Oney, S., Sullenger, B.A.> ;Mol Ther. 2012 Feb
• Monoclonal antibody blockade of IL-2R{alpha} during lymphopenia selectively depletes regulatory T cells in mice and humans.
  Mitchell, D.A., Cui, X., Schmittling, R.J., Sanchez-Perez, L., Snyder, D.J., Congdon, K.L., Archer, G.E., Desjardins, A., Friedman, A.H., Friedman, H.S., Herndon, J.E....> ;Blood. 2011 Sep 15
• A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
  Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A, Snyder D, Pullarkat V, Kogut N, Rosenthal J, Smith E, Karanes C, O'Donnell M, Krishnan AY, Senitz...> ;Blood. 2010-02-04
• Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on ch...
  Rodriguez R, Nademanee A, Palmer JM, Parker P, Nakamura R, Snyder D, Pullarkat V, Zain J, Smith E, Sahebi F, Patane K, Senitzer D, Chang K, Forman SJ> ;Bone Marrow Transplant.. 2010-01-01
• Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
  Wang S, Nademanee A, Qian D, Dagis A, Park H, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, K...> ;Transfusion. 2007-12-01
• Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
  Bhatia S, Francisco L, Carter A, Sun C, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NKC, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ> ;Blood. 2007-11-15
• A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplant...
  Nademanee A, Forman S, Molina A, Fung H, Smith D, Dagis A, Kwok C, Yamauchi D, Anderson A, Falk P, Krishnan A, Kirschbaum M, Kogut N, Nakamura R, O'donnell M, Parker P...> ;Blood. 2005-10-15
• The use of daclizumab for treatment of steroid refractory acute GVHD. A City of Hope experience.
  Zain JM, Smith E, Palmer J, Parker P, Snyder D, Rodriguez R, Nakamura R, Pullarkat V, Al-Kadhimi Z, Rosenthal J, Smith D> ;J. Clin. Oncol.. 2005-06-01
• Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.
  Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadhimi Z, Bhatia R, Cohen S, Falk P, Fung H, Kirschbaum M, Krishnan A, Kogut N, Molina A, Nakamura R, O'Donnell M, Pop...> ;Biol. Blood Marrow Transplant.. 2005-04-01
• Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
  Weisdorf DJ, Anasetti C, Antin JH, Kernan NA, Kollman C, Snyder D, Petersdorf E, Nelson G, McGlave P> ;Blood. 2002-03-15
• Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.
  Kashyap A, Kandeel F, Yamauchi D, Palmer JM, Niland JC, Molina A, Fung H, Bhatia R, Krishnan A, Nademanee A, O'Donnell MR, Parker P, Rodriguez R, Snyder D, Spielberger...> ;Biol. Blood Marrow Transplant.. 2000-01-01
• Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.
  Margolin KA, Van Besien K, Wright C, Niland J, Champlin R, Fung HC, Kashyap A, Molina A, Nademanee AP, O'Donnell MR, Parker P, Smith E, Spielberger R, Somlo G, Snyder ...> ;Biol. Blood Marrow Transplant.. 1999-01-01
• Join now to see all